Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Obesity and Overweight · Binge Eating Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Clinical Research Coordinator) · abisson2@jh.edu · 667-306-9366

Study leads

Ariana M Chao, PhD, CRNP, FNP-BC
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Electric Stimulation Therapy · Obesity · Weight Loss

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Autosomal Dominant Polycystic Kidney · Obesity

Abroad (travel likely)RecruitingPHASE2

Aurora, United States

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Daphne, United States · Fairhope, United States

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

Healthy Participants · Obesity

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Brooklyn, United States